2-Methyl-2-propanyl (2R)-2-(2-hydroxyethyl)-4-morpholinecarboxylate(CAS: 136992-21-7)

This compound is subject to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), which includes classification for health hazards, flammability, and reactivity. It is regulated under the EU REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) for registration and information reporting. In the US, the EPA and FDA may also have specific requirements for its handling, storage, and use in food or pharmaceutical applications.

Alternative reagents include 2-(2-hydroxyethyl)-4-morpholinecarboxylic acid and its derivatives. Isomers such as (2S)-2-(2-hydroxyethyl)-4-morpholinecarboxylate can also be used as substitutes, depending on the specific reaction conditions. Common synthetic equivalents include morpholine-based compounds and their derivatives.

The market is largely driven by its use in pharmaceutical and cosmetic industries. Research trends focus on its improvement as a drug delivery system and its application in topical formulations. Market demand is expected to grow due to increasing R&D activities and its potential in niche applications such as advanced wound care and dermatological treatments.

Waste containing this compound should be collected in appropriate containers and stored in a cool, well-ventilated area away from sources of ignition. It should be disposed of through a professional waste disposal service that is compliant with local and international regulations. Environmental protection measures should include proper labeling and documentation of waste streams to ensure safe and efficient disposal.